Abstract:Recombinant human procollagenase-3 and a C-terminal truncated form (Delta249-451 procollagenase-3) have been stably expressed in myeloma cells and purified. The truncated proenzyme could be processed by aminophenylmercuric acetate via a short-lived intermediate form (N-terminal Leu58) to the final active form (N-terminal Tyr85). The kinetics of activation were not affected by removal of the hemopexin-like C-terminal domain. The specific activities of both collagenase-3 and Delta249-451 collagenase-3 were found to be similar using two quenched fluorescent substrates, but Delta249-451 collagenase-3 failed to cleave native triple helical collagens (types I and II) into characteristic one- and three-quarter fragments. It was noted, however, that the beta1,2(I) chains of type I collagen were susceptible to Delta249-451 collagenase-3, which indicates that the catalytic domain displays telopeptidase activity, thereby generating alpha1,2(I) chains that are slightly shorter than those in native type I collagen. It can be concluded that the C-terminal domain is only essential for the triple helicase activity of collagenase-3. Binding of procollagenase-3 and active collagenase-3 to type I collagen is mediated by the C-terminal domain. Both collagenase-3 and Delta249-451 collagenase-3 hydrolyzed the large tenascin C isoform, fibronectin, recombinant fibronectin fragments, and type IV, IX, X, and XIV collagens; thus, these events were independent from C-terminal domain interactions. In contrast, the minor cartilage type XI collagen was resistant to cleavage. Kinetic analysis of the mechanism of inhibition of wild-type and Delta249-451 collagenase-3 by wild-type and mutant tissue inhibitors of metalloproteinase (TIMPs) revealed that the association rates for complex formation were influenced by both N- and C-terminal domain interactions. The C-terminal domain of wild-type collagenase-3 promoted increased association rates with the full-length inhibitors TIMP-1 and TIMP-3 and the hybrid N.TIMP-2/C.TIMP-1 by a factor of up to 33. In contrast, the association rates for complex formation with TIMP-2 and N.TIMP-1/C.TIMP-2 were only marginally affected by C-terminal domain interactions.

Activation of human gingival collagenase

Engineering the Periodontal Ligament in Hyaluronan-Gelatin-type I Collagen Constructs: Upregulation of Apoptosis and Alterations in Gene Expression by Cyclic Compressive Strain.

Proteolytic activities of human fibroblast collagenase: hydrolysis of a broad range of substrates at a single active site

Purification and characterization of a protease from Porphyromonas gingivalis capable of degrading salt-solubilized collagen

MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen.

Analysis of contribution of collagen fibre component in viscoelastic behaviour of periodontal ligament using enzyme probe

Characteristics of neutral proteases present in inflamed human gingiva

TGF-β Activity Related to the use of Collagen Membranes: In Vitro Bioassays

The roles of histidine and tyrosine residues in the active site of collagenase in Grimontia hollisae

Collagen synthesis by human fibroblasts. Regulation by transforming growth factor-beta in the presence of other inflammatory mediators.

Crystal structure of Grimontia hollisae collagenase provides insights into its novel substrate specificity toward collagen

Interleukin-1 alpha stimulates interstitial collagenase gene expression in human dental pulp fibroblast

In Vitro Enzymatic Degradation of Tissue Grafts and Collagen Biomaterials by Matrix Metalloproteinases: Improving the Collagenase Assay.

AFM study of the effects of collagenase and its inhibitors on dentine collagen fibrils.

The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction

Insights into the catalytic mechanism of Grimontia hollisae collagenase through structural and mutational analyses

Characterization of the Phe-81 and Val-82 human fibroblast collagenase catalytic domain purified from Escherichia coli

Real-time Enzymatic Degradation of Human Dentin Collagen Fibrils Exposed to Exogenous Collagenase: an AFM Study in Situ

Validation of a rapid collagenase activity detection technique based on fluorescent quenched gelatin with synovial fluid samples

Comparative studies on the activities of collagenases from Grimontia hollisae and Clostridium hystoliticum in the hydrolysis of synthetic substrates

Bioavailable affinity label for collagen prolyl 4-hydroxylase